ACTIVE INGREDIENT
Active Ingredient: Glycerin 2.23%
Active Ingredient: Glycerin 2.23%
Inactive Ingredients: Snail Secretion Filtrate, Hydrogenated Polydecene, Cetearyl Alcohol, Niacinamide, Macadamia Ternifolia Seed Oil, Cetyl Ethylhexanoate, Glycol Stearate SE, Butyrospermum Parkii (Shea Butter), Octyldodecyl Myristate, Caprylic/Capric Triglyceride, Sodium Hyaluronate, Limnanthes Alba (Meadowfoam) Seed Oil, Hydrogenated Vegetable Oil, Propanediol, Glyceryl Stearate, Dimethicone, Beeswax, PEG-100 Stearate, Tocopheryl Acetate, Polyacrylate-13, Laureth-23, Stearic Acid, Hydrogenated Lecithin, Panthenol, Polyisobutene, Citrus Medica Limonum (Lemon) Peel Oil, Centella Asiatica Extract, Imperata Cylindrica Root Extract, Adenosine, Butylene Glycol, Citrus Aurantium Bergamia (Bergamot) Fruit Oil, Sorbitan Isostearate, Polysorbate 20, Citrus Aurantium Dulcis (Orange) Peel Oil, Citrus Aurantifolia (Lime) Oil, PEG-8, Pinus Sylvestris Leaf Oil, Eucalyptus Globulus Leaf Oil, Carbomer, Disodium EDTA, Ethylhexylglycerin, Caprylyl Glycol, Chlorphenesin, Phenoxyethanol
Purpose: Skin Protectant
Warnings: 1. In case of having following symptoms after using this, you're advised to stop using it immediately. If you keep using it, the symptoms will get worse and need to consult a dermatologist. 1) In case of having problems such as red rash, swollenness, itching, stimulation during usage. 2) In case of having the same symptoms above on the part you put this product on by direct sunlight. 2. You are banned to use it on the part where you have a scar, eczema, or dermatitis. 3. In case of getting it into your eyes, you have to wash it immediately.
Keep out of reach of Children: Keep out of reach of babies and children
Indication & Usage: After using eye cream, apply a pea sized amount evenly distribute across the face. Gently pat for better absorption.
Dosage & Administration: Take an adequate amount of this product.
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 59078-054-01 | 2025-11-09 | C162847 | 48780-1 | 9d75b9cf-d72a-f424-e053-dadaa90a57ce | 8f01cc08-f140-4931-888d-973b7d9057e5 |
| 59078-054-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-d72a-f424-e053-dadaa90a57ce | 8f01cc08-f140-4931-888d-973b7d9057e5 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Glycerin | ACTIVE INGREDIENT | PDC6A3C0OX | 2 | |
| GLYCERIN | ACTIVE MOIETY | PDC6A3C0OX | 2 | |
| Niacinamide | INACTIVE INGREDIENT | 25X51I8RD4 | 2 | |
| SHEA BUTTER | INACTIVE INGREDIENT | K49155WL9Y | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 59078-054 | 59078-054-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Glycerin | PDC6A3C0OX | ACTIB |
| Niacinamide | 25X51I8RD4 | IACT |
| SHEA BUTTER | K49155WL9Y | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Niacinamide | NIACINAMIDE | 25X51I8RD4 | GEL / TOPICAL | 25 mg | ||
| Niacinamide | NIACINAMIDE | 25X51I8RD4 | CREAM / TOPICAL | NA | ||
| Niacinamide | NIACINAMIDE | 25X51I8RD4 | INJECTION / INTRAVENOUS | 2.5 %w/v | ||
| Niacinamide | NIACINAMIDE | 25X51I8RD4 | INJECTION / INTRAMUSCULAR | 2.5 %w/v | ||
| SHEA BUTTER | SHEA BUTTER | K49155WL9Y | LOTION / TOPICAL | 2340 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 432989b1-59aa-74d0-e063-6294a90a90c6 | 8f01cc08-f140-4931-888d-973b7d9057e5 | 2025-11-09 | Warnings | 8f01cc08-f140-4931-888d-973b7d9057e5 |
Adverse event summaries are temporarily unavailable. Other product information remains available.